Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd (KOSE:A285130) on September 21, 2023. The Pharmaceutical business generated annual sales of KRW 313.9 billion in 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
58,200 KRW | -0.34% | -1.52% | -13.52% |
May. 09 | SK Chemicals Swings to Loss in Q1 | MT |
Apr. 26 | SK chemicals Unveils Blueprint for Circular Recycle? and Solutions | CI |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-13.52% | 774M | |
+7.70% | 41.95B | |
-19.34% | 22.3B | |
-14.02% | 13.46B | |
-7.95% | 9.95B | |
+18.73% | 7.89B | |
+8.74% | 6.85B | |
-27.93% | 5.56B | |
-23.30% | 3.66B | |
-21.64% | 3.29B |
- Stock Market
- Equities
- A285130 Stock
- News SK Chemicals Co.,Ltd
- Glenwood Private Equity signed a memorandum of understanding to acquire the Pharmaceutical business of SK Chemicals Co.,Ltd.